A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Condition: Prader-Willi Syndrome Interventions: Drug: Pitolisant oral tablets; Drug: Placebo oral tablet Sponsor: Harmony Biosciences, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials